Evidence map›Paper›PMID 31649033›Full record

ArticleThe Journal of biological chemistry2019

AKR1A1 is a novel mammalian

Colin T Stomberski, Puneet Anand, Nicholas M Venetos, Alfred Hausladen, Hua-Lin Zhou, Richard T Premont, Jonathan S Stamler

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.2field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Integration of NO and HPlant communications · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. The Ever-Expanding Influence of the Endothelial Nitric Oxide Synthase.Basic & clinical pharmacology & toxicology · 2025
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Identification of Protein Targets ofACS chemical biology · 2024
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Colin T StomberskiDepartment of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106; Institute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016.
Puneet AnandInstitute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016.
Nicholas M VenetosDepartment of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106; Institute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016.
Alfred HausladenInstitute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016.
Hua-Lin ZhouDepartment of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106; Institute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016.
Richard T PremontInstitute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016; Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio 44016.
Jonathan S StamlerInstitute for Transformative Molecular Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016; Harrington Discovery Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio 44016; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio 44016. Electronic address: jonathan.stamler@case.edu.
University School · USUniversity Hospitals of Cleveland · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Regulation of Beta-Adrenergic Receptor Signaling by S-NitrosylationP01HL075443 · NHLBI · DUKE UNIVERSITY · PI STAMLER, JONATHAN S. · 2004 to 2019
$26.1M
Project 3 - Personalized cystic fibrosis treatment strategies with synergistic therapies Identified in vitro.P01HL128192 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN · 2016 to 2020
$12.2M
Restoration and Function of S-Nitrosothiol in Stored BloodR01HL126900 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI JONATHAN S. STAMLER · 2016 to 2026
$5.0M
Novel Regulation of Renal Function by S-NitrosylationR01DK119506 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI JONATHAN S. STAMLER, Hualin Zhou · 2018 to 2026
$3.7M
NHLBI NIH HHS P01 HL075443NHLBI NIH HHS P01 HL128192NHLBI NIH HHS R01 HL126900NIDDK NIH HHS R01 DK119506NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Oxidative modification of Cys residues by NO results in

Indexed as

Aldehyde OxidoreductasesAldehyde ReductaseAnimalsCoenzyme AHumansKineticsMammalsMice, Inbred C57BLMice, KnockoutNADPNitric OxideOxidation-ReductionSignal TransductionS-NitrosothiolsAKR1A1 protein, humanAkr1a1 protein, mouseAldehyde OxidoreductasesAldehyde ReductaseCoenzyme Aformaldehyde dehydrogenase, glutathione-independentNADPNitric OxideS-nitroso-coenzyme AS-NitrosothiolsAKR1A1denitrosylasedenitrosylationenzyme kineticsenzyme purificationGSNO reductasemolecular modelingmutagenesisnitric oxideS-nitroso-coenzyme A reductaseS-nitrosylation

Identifiers

PMID31649033
PMCPMC6885624
OpenAlexW2981438514

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.